Evolution of free, complexed, and total serum prostate-specific antigen and their ratios during 1 year of follow-up of men with febrile urinary tract infection

Urology

Volumn 62, Issue 2, 2003, Pages 278-281

  Zackrisson, Björn ^a   Ulleryd, Peter ^b   Aus, Gunnar ^b   Lilja, Hans ^b   Sandberg, Torsten ^b   Hugosson, Jonas ^b  

^a Capio AB   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEVER; FOLLOW UP; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; STATISTICAL SIGNIFICANCE; URINARY TRACT INFECTION;

EID: 0042123586     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(03)00372-8     Document Type: Article

References (29)

1. Lilja H. A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest. 76:1985;1899-1903.
2. Christensson A., Laurell C.B., Lilja H. Enzymatic activity of prostate-specific antigen and its reaction with extra cellular serine protease inhibitors. Eur J Biochem. 194:1990;755-763.
3. Tcheten M.B., Oesterling J.E. The effect of prostatitis, urinary retention, ejaculation, and ambulation on the serum prostate-specific antigen concentration. Urol Clin North Am. 24:1997;283-291.
4. Furuya Y., Akakura K., Ichikawa T., et al. Effect of prostatic biopsy on free-to-total prostate-specific antigen ratio in patients with prostate cancer. Int J Urol. 7:2000;49-53.
5. Lechevallier E., Eghazarian C., Ortega J.C., et al. Effect of digital rectal examination on serum complexed and free prostate-specific antigen and percentage of free prostate-specific antigen. Urology. 54:1999;857-861.
6. Pansadoro V., Emiliozzi P., Defidio L., et al. Prostate-specific antigen and prostatitis in men under fifty. Eur Urol. 30:1996;24-27.
7. Neal D.E. Jr, Clejan S., Sarma D., et al. Prostate specific antigen and prostatitis. 1. Effect of prostatitis on serum PSA in the human and nonhuman primate. Prostate. 20:1992;105-111.
8. Speights V.O. Jr, Brawn P.N. Serum prostate specific antigen levels in non-specific granulomatous prostatitis. Br J Urol. 77:1996;408-410.
9. Wolff J.M., Borchers H., Effert P.J., et al. Free-to-total prostate-specific antigen serum concentrations in patients with prostate cancer and benign prostatic hyperplasia. Br J Urol. 78:1996;409-413.
10. Marley GM, Miller MC, Kattan MW, et al: Free and complexed prostate-specific antigen serum ratios to predict probability of primary prostate cancer and benign prostatic hyperplasia. Urology 48(6A suppl): 16-22, 1996.
11. Wymenga L.F., Duisterwinkel F.J., Groenier K., et al. Clinical implications of free-to-total immunoreactive prostate-specific antigen ratios. Scand J Urol Nephrol. 34:2000;181-187.
12. Tornblom M., Norming U., Adolfsson J., et al. Diagnostic value of percent free prostate-specific antigen retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL . Urology. 53:1999;945-950.
13. Oesterling J.E., Jacobsen S.J., Klee G.G., et al. Free, complexed and total serum prostate specific antigen the establishment of appropriate reference ranges for their concentrations and ratios . J Urol. 154:1995;1090-1095.
14. Ulleryd P., Zackrisson B., Aus G., et al. Prostatic involvement in men with febrile urinary tract infection as measured by serum prostate-specific antigen and transrectal ultrasonography. BJU Int. 84:1999;470-474.
15. Rubin R.H., Shapiro E.D., Andriole V.T., et al. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Clin Infect Dis. 15:1992;S216-S227.
16. Piironen T, Pettersson K, Suonpaa M, et al: In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin in blood samples. Urology 48(6A suppl): 81-87, 1996.
17. Mitrunen K., Pettersson K., Piironen T., et al. Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum. Clin Chem. 41:1995;1115-1120.
18. Pettersson K., Piironen T., Seppala M., et al. Free and complexed prostate-specific antigen (PSA) in vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-alpha 1-antichymotrypsin complex . Clin Chem. 41:1995;1480-1488.
19. 1-antichymotrypsin from serum. Urology. 51:1998;57-62.
20. Hasui Y., Marutsuka K., Asada Y., et al. Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia. Prostate. 24:1994;91-96.
21. Nadler R.B., Humphrey P.A., Smith D.S., et al. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol. 154:1995;407-413.
22. Okada K., Kojima M., Nay Y., et al. Correlation of histological inflammation in needle biopsy specimens with serum prostate-specific antigen levels in men with negative biopsy for prostate cancer. Urology. 55:2000;892-898.
23. Recker F., Kwiatkowski M.K., Pettersson K., et al. Enhanced expression of prostate-specific antigen in the transition zone of the prostate a characterization following prostatectomy for benign hyperplasia . Eur Urol. 33:1998;549-555.
24. Bjartell A., Björk T., Matikainen M.T., et al. Production of alpha-1- antichymotrypsin by PSA-containing cells of human prostate epithelium. Urology. 42:1993;502-510.
25. Björk T., Bjartell A., Abrahamsson P.A., et al. Alpha 1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatic hyperplasia. Urology. 44:1994;296-297.
26. Martinez-Pineiro L., Tabernero A., Contreras T., et al. Determination of the percentage of free prostate-specific antigen helps to avoid unnecessary biopsies in men with normal rectal examinations and total prostate-specific antigen of 4-10 ng/ml. Eur Urol. 37:2000;289-296.
27. Lieberman S. Can percent free prostate-specific antigen reduce the need for prostate biopsy? Eff Clin Pract. 2:1999;266-271.
28. Scattoni V., Raber M., Montorsi F., et al. Percent of free serum prostate specific antigen and histological findings in patients undergoing open prostatectomy for benign prostatic hyperplasia. Eur Urol. 36:1999;621-630.
29. Jung K., Meyer A., Lein M., et al. Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate. J Urol. 159:1998;1595-1598.